MENU

Donald Trump threatens to put a $200 billion bomb under share markets

Traders will be glued to the unconventional Twitter feed of Donald Trump this afternoon due to threats the U.S. President is making to impose tariffs on an additional US$200 billion of Chinese imports into the U.S.

Midnight tonight U.S. time (2pm AEST) was a reported deadline for an announcement (or tweet) over the imposition of the tariffs, but as Australian traders pack up for the weekend there appears no news from Washington.

Trade wars and tariffs are generally bad for stock prices as if trade shrinks so does gross domestic product and rates of global growth.

As a result of the tensions the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) looks poised to extend a week-long losing streak as buyers disappear ahead of what could be another weekend of news headlines around a trade war with any number of major economies including Canada, China, Japan and Germany.

Another consequence of the trade fights is the falling Australian dollar that will help the bottom lines of companies earning revenues and profits overseas before reporting earnings in Aussie dollars.

A couple of offshore earning large caps available available at much cheaper prices than this time last week include Macquarie Group Ltd (ASX: MQG), Cochlear Ltd (ASX: COH) and Amcor Limited (ASX: AMC).

The primary headwind facing the Aussie dollar are traders’ expectations that the Reserve Bank is not likely to lift rates until well into 2019 at the earliest. As such it’s possible the dollar continues to slide lower over the 12 – 18 months ahead. Companies earning money offshore then could continue to receive share price support in this macro environment.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd. and Macquarie Group Limited. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.